Skip to main content

International Stem Cell CORP

ISCO
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001355790

In the last 90 days, International Stem Cell CORP insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Superinvestors holding ISCO, Q2 2026

See all superinvestors

No superinvestor reported holding ISCO in Q2 2026.